First, the virus must get inside the cell. Every virus does this slightly differently, but most use their signature “spikes” to fuse themselves to a cell’s outer membrane and then squeeze their way inside.
Tollovid + Acute Infections
Exploring 3CL Protease inhibition in an active infection
Tollovid is helping those suffering from an active infection to feel better.
Acute COVID-19 or SARS-CoV-2 is still impacting millions of people. However, many people are reporting benefits against active infections with Tollovid.
of Acute COVID-19 respondents reported a decrease in Acute COVID-19 Symptoms.
of Acute COVID-19 respondents reported that they were happy with their results.
Case Studies: Key Highlights
CASE STUDY 7
Acute & Long COVID Patient Sees Resolution with Tollovid®
“She took 12 Tollovid capsules daily for 5 days, and saw her symptoms completely resolve in 3 – 4 days.”
Symptoms Include: Fatigue, Joint Pain, Fever, Clammy Hands, and Vision Issues
How Tollovid™ Works:
1. Binding & Entry
Once inside, the virus RNA instructs the cell to make a long polypeptide containing special enzymes. This long protein must be cut apart for the virus to replicate. To accomplish this, the virus encodes a special ‘scissors’, called 3CL protease, which cuts up the polypeptide into the different enzymes that then become functional.
Before these enzymes can start working, they need to be separated from each other. The protease enzyme acts like a pair of scissors, cutting the polypeptide up into the different enzymes that then become functional.
4. 3CL Protease Inhibitors
Protease inhibitors, like Tollovid, are designed to tightly bind to the protease enzyme, blocking its ability to cut. This shuts down the entire virus-making apparatus, leaving it unable to make a single virus.